Thymosin fraction V and intensive combination chemotherapy. Prolonging the survival of patients with small-cell lung cancer.

Cohen, M H

Thymosin fraction V and intensive combination chemotherapy. Prolonging the survival of patients with small-cell lung cancer. [electronic resource] - JAMA Apr 1979 - 1813-5 p. digital

Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial

0098-7484

10.1001/jama.241.17.1813 doi


Antineoplastic Agents--administration & dosage
Carcinoma, Small Cell--drug therapy
Cyclophosphamide--administration & dosage
Doxorubicin--administration & dosage
Drug Therapy, Combination
Etoposide--administration & dosage
Female
Humans
Ifosfamide--administration & dosage
Lomustine--administration & dosage
Lung Neoplasms--drug therapy
Male
Methotrexate--administration & dosage
Procarbazine--administration & dosage
Thymosin--administration & dosage
Thymus Hormones--administration & dosage
Vincristine--administration & dosage